Financial
information
Hofseth BioCare aim to serve the financial market with precise and relevant information about the company to ensure that the share price reflects the underlying values and future prospects. In this section you will find the latest news, presentations, reports and other useful information.
Stock Exchange Notices
- 2017-05-29: Hofseth Biocare ASA : Completed annual general meeting
- 2017-05-11: Hofseth Biocare ASA: First Quarter 2017 Financial Report
- 2017-05-04: Hofseth Biocare ASA: Call for Annual General Meeting
- 2017-03-31: Hofseth Biocare ASA: HBC Annual Report 2016 approved and completes sale and long-term leaseback contracts
- 2017-03-24: Hofseth Biocare ASA: Completes Extraordinary General Meeting in HBC
- 2017-03-23: Hofseth Biocare ASA: PROXIES TO VOTE FOR 20.06 % OF THE SHARES AT EGM - DISCLOSURE OF LARGE SHAREHOLDING
- 2017-03-08: Hofseth Biocare ASA: Disclosure of large shareholdings in Hofseth BioCare ASA
- 2017-03-03: Hofseth Biocare ASA: ENTERS INTO AGREEMENT FOR SALE AND LONG TERM LEASE CONTRACTS OF PROPERTIES - CALL FOR GENERAL MEETING
- 2017-02-15: Hofseth Biocare ASA: Fourth Quarter 2016 Financial Report
- 2017-01-13: Hofseth Biocare ASA: SHARE PURCHASE
Archive
Why Hofseth BioCare?
- New advanced proprietary process technology
- Producing premium products
- Attractive market proposition
- State of the art production facilities
- Attractive partner model for further growth
- Upside potential within pharma segments
- Management with highly relevant experience
